FDA DrugClass IINotable
FDA Recall: Semaglutide, For Rx compounding use only, packaged in a) 1g, NDC 84385-106-01; b) 5g, NDC 84385-106-
Description
CGMP Deviations This recall has been initiated due to failing to complete process validation and bacterial endotoxin method validation before distribution
Hazard
CGMP Deviations This recall has been initiated due to failing to complete process validation and bacterial endotoxin method validation before distribution
Remedy
N/A
Related Recalls
2026-06-17 · FDA_DRUG
FDA Recall: DOXOrubin Hydrochloride Liposome injection, 50 mg/25 mL (2mg/mL), 25 mL single-dose vials, Sterile,
SUN PHARMACEUTICAL INDUSTRIES INC
2026-06-17 · FDA_DRUG
FDA Recall: Duloxetine Delayed-Release Capsules, USP, 30mg, 1000 Capsule bottles, Rx only, Manufactured. by: Tow
Breckenridge Pharmaceutical, Inc.
2026-06-17 · FDA_DRUG
FDA Recall: GSMS Incorporated, NIACIN EXTENDED-RELEASE TABLETS, USP, 1,000 MG, 90 tablets, Rx only, Manufactured
Golden State Medical Supply Inc.
2026-06-17 · FDA_DRUG
FDA Recall: Primidone Tablets, USP, 50 mg, 100 Tablets per Bottle, Rx only, Manufactured by: Amneal Pharmaceutic
Amneal Pharmaceuticals, LLC